Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Allistair Abraham, MD
Children's National, Washington DC
Principal Investigator - Franco Locatelli, MD
IRCCS Ospedale Pediatrico Bambino Gesu, Rome, Italy
Principal Investigator - Jean-Hugues Dalle, MD
Robert Debre, Paris, France
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hôpital Robert Debré
Paris, France
- Ucsf Benioff Children'S Hospital
Oakland, California, United States
- Children'S National
Washington D.C., District of Columbia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Apr 2016
- Primary completion
- 31 Aug 2016
- Completion
- 31 Dec 2017
- Last update posted
- 26 Jun 2019
- Registered enrollment
- 1
- Registry id
- NCT02504619
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.